Skip to content

    Recently Viewed


      Home / Latest news /
      Chairman and CEO Alex Gorsky discusses Johnson & Johnson’s response to COVID-19 at the Fortune Brainstorm Health Conference
      lede-Chairman and CEO Alex Gorsky Discusses Johnson & Johnson's Response to COVID-19 at the Fortune Brainstorm Health Conference.jpg

      Chairman and CEO Alex Gorsky discusses Johnson & Johnson’s response to COVID-19 at the Fortune Brainstorm Health Conference

      Watch a video of Gorsky’s interview at the virtual summit, which includes the latest information on the company’s pursuit of a potential COVID-19 vaccine.

      Share Article
      share to

      As a former U.S. Army Captain, Alex Gorsky knows how to lead a battle. And right now, the Johnson & Johnson Chairman and CEO, alongside employees across the globe, is hard at work innovating solutions in the battle against COVID-19.

      Innovations like a potential COVID-19 vaccine, which the company started working on in January. In June, Johnson & Johnson announced it was accelerating the initiation of the Phase 1/2a human clinical trial for its investigational vaccine candidate.

      Yesterday, Gorsky appeared as a featured speaker at the annual Fortune Brainstorm Health conference, which focused this year on what we’ve learned from the COVID-19 pandemic, how we can weather the continuing storm—and prepare for the next.

      Watch his interview with conference co-chair David Agus, M.D., Founding Director and CEO of the Lawrence J. Ellison Institute for Transformative Medicine at the University of Southern California, in the video below.

      Gorsky discussed Johnson & Johnson’s response to the pandemic, the company’s rapid progress toward advancing a vaccine—and how COVID-19 has affected virtually every aspect of health and medical care.

      “Hopefully some of the lessons we’re learning now in working with different entities can lead to the kind of collaborations we continue in the future,” Gorsky says. “That could be one of the silver linings in the long term that the industry and healthcare systems take away.”


      Video courtesy of FORTUNE

      Tune in live each week to watch season 2 of “The Road to a Vaccine”

      The video series, hosted by journalist and author Lisa Ling, delves into efforts to create a potential COVID-19 vaccine.

      More from Johnson & Johnson

      Latest news
      Q1 2024-1x1.png

      What you need to know about Johnson & Johnson’s 2024 first-quarter earnings

      Here’s an infographic breakdown of the company’s first-quarter earnings results, including key highlights from its Innovative Medicine and MedTech businesses.
      Latest news
      healthcare worker in protective medical gear

      Johnson & Johnson named to Fortune’s 2024 America’s Most Innovative Companies list

      The company’s drive to develop novel solutions for the world’s toughest healthcare challenges has earned it a spot on Fortune’s second annual list.
      Headshots of three Johnson and Johnson female scientists

      Meet 3 leaders who are breaking new ground for women in healthcare

      For International Women’s Day, celebrate the achievements of these amazing female scientists and researchers at Johnson & Johnson.
      You are now leaving The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.